These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25023331)
1. Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%. Murina F; Rehman S; Di Francesco S; Mantegazza V; Felice R; Bianco V J Low Genit Tract Dis; 2015 Apr; 19(2):149-51. PubMed ID: 25023331 [TBL] [Abstract][Full Text] [Related]
2. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial. Corazza M; Borghi A; Minghetti S; Toni G; Virgili A J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):956-61. PubMed ID: 25904498 [TBL] [Abstract][Full Text] [Related]
3. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? Corazza M; Virgili A; Toni G; Borghi A J Dermatolog Treat; 2018 May; 29(3):305-309. PubMed ID: 28753097 [TBL] [Abstract][Full Text] [Related]
4. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability. Virgili A; Borghi A; Toni G; Minghetti S; Corazza M Br J Dermatol; 2014 Aug; 171(2):388-96. PubMed ID: 24641522 [TBL] [Abstract][Full Text] [Related]
5. Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial. Borghi A; Corazza M; Minghetti S; Toni G; Virgili A Br J Dermatol; 2015 Dec; 173(6):1381-6. PubMed ID: 26280156 [TBL] [Abstract][Full Text] [Related]
6. Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? Borghi A; Minghetti S; Toni G; Virgili A; Corazza M J Dermatolog Treat; 2017 Sep; 28(6):559-563. PubMed ID: 28024127 [TBL] [Abstract][Full Text] [Related]
7. Topical interventions for genital lichen sclerosus. Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Tolerability of Mometasone Furoate in Lichen Sclerosus: Further Confirming Evidence. Virgili A; Minghetti S; Corazza M; Borghi A J Low Genit Tract Dis; 2015 Jul; 19(3):e58. PubMed ID: 26111043 [No Abstract] [Full Text] [Related]
9. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. Virgili A; Minghetti S; Borghi A; Corazza M Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459 [TBL] [Abstract][Full Text] [Related]
10. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus. Virgili A; Corazza M; Minghetti S; Borghi A Maturitas; 2015 Jan; 80(1):113-5. PubMed ID: 25449823 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. Funaro D; Lovett A; Leroux N; Powell J J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment]. Sun XY; Xiao YP; Sun YX; Zhang Q; Cong Q Zhonghua Fu Chan Ke Za Zhi; 2024 Jan; 59(1):56-63. PubMed ID: 38228516 [No Abstract] [Full Text] [Related]
13. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment. Borghi A; Corazza M; Minghetti S; Toni G; Virgili A J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682 [TBL] [Abstract][Full Text] [Related]
14. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients. Virgili A; Borghi A; Minghetti S; Corazza M J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234 [TBL] [Abstract][Full Text] [Related]
16. Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment. Corazza M; Maietti E; Toni G; Virgili A; Borghi A Dermatol Ther; 2018 Nov; 31(6):e12735. PubMed ID: 30334327 [TBL] [Abstract][Full Text] [Related]
17. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Ayhan A; Guven S; Guvendag Guven ES; Sakinci M; Gultekin M; Kucukali T Int J Gynaecol Obstet; 2007 Feb; 96(2):117-21. PubMed ID: 17239881 [TBL] [Abstract][Full Text] [Related]
18. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial. Terras S; Gambichler T; Moritz RK; Stücker M; Kreuter A JAMA Dermatol; 2014 Jun; 150(6):621-7. PubMed ID: 24696010 [TBL] [Abstract][Full Text] [Related]
19. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets. Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK; Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study. Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]